ADAM17 and neoplasm: showed that a disintegrin and metalloprotease (ADAM)10 and ADAM17 cleave PD-L1 from the surface of malignant cells, thereby producing sPD-L1 that induces apoptosis in CD8+ T cells and compromises the killing of tumor cells by CD8+ T cells (15).